Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Post Market Drug Safety and Effectiveness

University of British Columbia

$85,000.00

Population Incidence of Serious Cardiovascular EventS and medications for attention deficit hyperactivity disorder (PISCES)

EF 2009-10

Résumé
Our study will aim to determine whether medications for attention deficit hyperactivity disorder are associated with cardiovascular side effects such as heart attack, stroke, irregular heart rate or sudden death. Our analysis will include all ages, including youth 6 to 18 years of age. The population for the study will include residents of British Columbia and Medicaid patients from the United States.
Programme
Catalyst Grant: Post Market Drug Safety and Effectiveness
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
192763
Name
Dormuth Colin R
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Projecttitle
Population Incidence of Serious Cardiovascular EventS and medications for attention deficit hyperactivity disorder (PISCES)
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$85,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Keyworddelim
Attention Deficit Hyperactivity Disorder; Cardiovascular; Drug Safety; Propensity Scores; Serious Adverse Events; Stimulants
Abstract
Our study will aim to determine whether medications for attention deficit hyperactivity disorder are associated with cardiovascular side effects such as heart attack, stroke, irregular heart rate or sudden death. Our analysis will include all ages, including youth 6 to 18 years of age. The population for the study will include residents of British Columbia and Medicaid patients from the United States.
Competitiondate
200910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dormuth, Colin R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $85,000~ $0~